CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 139 filers reported holding CARA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $10,000 | – | 800 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,568,057 | $70,005,000 | 74.08% |
| Chescapmanager LLC | 1,203,055 | $23,604,000 | 2.80% |
| Mesirow Financial Investment Management, Inc. | 29,821 | $585,000 | 2.32% |
| DAFNA Capital Management LLC | 143,611 | $2,818,000 | 1.22% |
| Opaleye Management Inc. | 200,000 | $3,924,000 | 1.09% |
| SPHERA FUNDS MANAGEMENT LTD. | 303,930 | $5,963,000 | 0.54% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 852,892 | $16,734,000 | 0.29% |
| DLD Asset Management, LP | 352,700 | $6,927,000 | 0.26% |
| SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 54,984 | $1,079,000 | 0.18% |
| B. Riley Wealth Management, Inc. | 33,755 | $662,000 | 0.12% |